VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,765 | -49.7% | 623 | -43.7% | 0.01% | -57.9% |
Q2 2023 | $33,302 | -82.2% | 1,106 | -80.9% | 0.02% | -81.4% |
Q1 2023 | $187,048 | -25.8% | 5,782 | -34.2% | 0.10% | -27.7% |
Q4 2022 | $251,950 | +2190.5% | 8,791 | +1853.6% | 0.14% | +1914.3% |
Q3 2022 | $11,000 | -99.9% | 450 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $12,321,000 | +87907.1% | 450 | 0.0% | 0.01% | -22.2% |
Q4 2021 | $14,000 | -46.2% | 450 | -50.0% | 0.01% | -40.0% |
Q3 2021 | $26,000 | +62.5% | 900 | +100.0% | 0.02% | +15.4% |
Q2 2021 | $16,000 | – | 450 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |